CME Group to Release Quarterly Earnings on October 23

by Yuki

CME Group Inc. (NASDAQ) is set to announce its quarterly earnings before the market opens on Wednesday, October 23. Analysts anticipate the company will report earnings of $2.48 per share for the quarter. Those interested in the earnings call can access it through the provided link.

Previous Earnings Performance

CME Group’s last earnings report was released on July 24, where the company reported earnings of $2.56 per share, exceeding analysts’ expectations of $2.53 by $0.03. Revenue for that quarter reached $1.53 billion, aligning with analyst projections. The company recorded a net margin of 56.98% and a return on equity of 12.82%, marking a 12.7% increase in revenue year-over-year. In the same period last year, CME Group reported earnings of $2.30 per share. Looking ahead, analysts expect CME Group to achieve earnings of $10 per share for both the current and next fiscal years.

Market Performance and Financial Metrics

As of Monday, CME Group shares opened at $228.32. The company has a 50-day moving average of $216.92 and a 200-day moving average of $208.32. With a market capitalization of $82.21 billion, CME Group’s price-to-earnings (P/E) ratio stands at 25.97, while its price-to-earnings growth (PEG) ratio is 7.76. The stock has experienced a 1-year low of $190.70 and a high of $230.12. Additionally, the company maintains a debt-to-equity ratio of 0.10, alongside a quick ratio and current ratio of 1.02 each.

Dividend Update

Recently, CME Group announced a quarterly dividend of $1.15 per share, which was paid on September 25 to stockholders of record as of September 9. This translates to an annualized dividend of $4.60 and a yield of 2.01%. The company’s payout ratio currently stands at 52.33%.

Insider Transactions

In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock on September 15, at an average price of $216.99, amounting to a total value of approximately $163,610. Following this transaction, Fitzpatrick retains ownership of 13,261 shares valued at around $2.88 million. Similarly, Director Bryan T. Durkin sold 7,593 shares on August 30 at an average price of $214.59, totaling approximately $1.63 million. Durkin now holds 55,607 shares valued at about $11.93 million. Insiders own approximately 0.30% of the company’s stock.

Analyst Ratings

CME Group has garnered attention from various research analysts recently. TD Cowen initiated coverage with a “hold” rating and a price target of $221. Goldman Sachs raised its price target from $195 to $198 but maintained a “sell” rating. Deutsche Bank also increased its target from $193 to $200 with a “hold” rating. Piper Sandler lifted its price target from $225 to $240, rating the stock as “overweight.” Oppenheimer has increased its target from $228 to $245, rating it as “outperform.” Currently, four analysts rate the stock as a sell, seven as hold, and four as buy, resulting in an average rating of “Hold” and a consensus price target of $220.07, according to MarketBeat.com.

About CME Group

CME Group Inc., along with its subsidiaries, operates global contract markets for trading futures and options on futures contracts. The company offers a diverse range of products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, metals, and provides trading services in fixed income and foreign currencies.

Related topic:

What Is Cme Futures?

How To Trade Cme Futures?

How Do CME Futures Work?

Related Articles

blank

Welcome to sorafutures futures portal! Here, we illuminate pathways to tomorrow’s opportunities, equipping you with insights and resources to thrive in an ever-evolving world. With a blend of vision and pragmatism, we empower individuals to navigate uncertainties and seize their future with confidence.

Copyright © 2023 sorafutures.com